CAS 1426698-88-5

Formula: C20H22ClFN6O2

InChI: InChI=1S/C20H22ClFN6O2/c1-4-30-18-12(6-13(21)17(22)16(18)11-5-14(29)24-7-11)10(3)28-20-15(9(2)27-28)19(23)25-8-26-20/h6,8,10-11H,4-5,7H2,1-3H3,(H,24,29)(H2,23,25,26)/t10-,11-/m0/s1

InChI key: ZQPDJCIXJHUERQ-QWRGUYRKSA-N

SMILES: CCOC1=C(C(=C(C=C1[C@H](C)N2C3=NC=NC(=C3C(=N2)C)N)Cl)F)[C@H]4CC(=O)NC4

Parsaclisib

CAS: 1426698-88-5

Parsaclisib

Formula: C₂₀H₂₂ClFN₆O₂

Purity: 98.5%

Color and Shape: Solid

Molecular weight: 432.88

Ref: 54-BUP04207

Parsaclisib

CAS: 1426698-88-5

Parsaclisib (INCB050465) is a potent and selective inhibitor of PI3Kδ(IC50 of 1 nM at 1 mM ATP)

Formula: C₂₀H₂₂ClFN₆O₂

Purity: 98.59%

Color and Shape: Solid

Molecular weight: 432.879

Ref: TM-T12367

Parsaclisib

CAS: 1426698-88-5

Ref: IN-DA01EOAM

(R)-4-(3-((S)-1-(4-Amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one

CAS: 1426698-88-5

Formula: C₂₀H₂₂ClFN₆O₂

Purity: 99%

Molecular weight: 432.88

Ref: IN-DG00777489

Parsaclisib

CAS: 1426698-88-5

Parsaclisib is a secretase inhibitor that has been shown to be effective in treating multiple types of cancer, including lung, pancreatic, and colorectal cancers. It is also being investigated for use in the treatment of Alzheimer's disease and other autoimmune diseases. Parsaclisib inhibits the production of amyloid beta protein by reducing its production by inhibiting the enzyme β-secretase. This drug has been shown to increase glomerular filtration rate (GFR) in patients with chronic kidney disease. Parsaclisib is a promising drug for the treatment of infectious diseases such as HIV/AIDS because it suppresses viral replication without affecting normal cells.

Formula: C₂₀H₂₂ClFN₆O₂

Purity: Min. 95%

Molecular weight: 432.9 g/mol

Ref: 3D-BHC69888